Aljian Capital Management LLC Buys Shares of 3,200 STERIS plc (NYSE:STE)

Aljian Capital Management LLC acquired a new stake in STERIS plc (NYSE:STE - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 3,200 shares of the medical equipment provider's stock, valued at approximately $776,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. West Coast Financial LLC boosted its stake in shares of STERIS by 2.8% during the 3rd quarter. West Coast Financial LLC now owns 1,640 shares of the medical equipment provider's stock worth $398,000 after acquiring an additional 45 shares during the period. Taylor Frigon Capital Management LLC increased its holdings in shares of STERIS by 0.8% in the second quarter. Taylor Frigon Capital Management LLC now owns 6,175 shares of the medical equipment provider's stock valued at $1,356,000 after purchasing an additional 46 shares during the last quarter. Mather Group LLC. raised its position in shares of STERIS by 7.6% in the second quarter. Mather Group LLC. now owns 763 shares of the medical equipment provider's stock valued at $172,000 after purchasing an additional 54 shares during the period. EverSource Wealth Advisors LLC lifted its stake in shares of STERIS by 16.5% during the 1st quarter. EverSource Wealth Advisors LLC now owns 402 shares of the medical equipment provider's stock worth $82,000 after buying an additional 57 shares during the last quarter. Finally, Waterloo Capital L.P. grew its stake in STERIS by 3.2% in the 2nd quarter. Waterloo Capital L.P. now owns 1,916 shares of the medical equipment provider's stock valued at $421,000 after buying an additional 59 shares during the last quarter. 94.69% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the company. Piper Sandler upgraded STERIS from a "neutral" rating to an "overweight" rating and boosted their price objective for the stock from $230.00 to $260.00 in a report on Thursday, October 24th. JMP Securities restated a "market outperform" rating and issued a $265.00 price target on shares of STERIS in a research note on Monday. Needham & Company LLC reiterated a "hold" rating on shares of STERIS in a research report on Friday, November 8th. StockNews.com downgraded STERIS from a "strong-buy" rating to a "buy" rating in a report on Tuesday, October 29th. Finally, KeyCorp upped their price target on shares of STERIS from $255.00 to $265.00 and gave the company an "overweight" rating in a research note on Tuesday, September 3rd. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $253.00.

STERIS Price Performance

Shares of STE traded down $3.08 during trading hours on Monday, hitting $217.04. 599,428 shares of the company were exchanged, compared to its average volume of 493,166. The company has a quick ratio of 1.55, a current ratio of 2.41 and a debt-to-equity ratio of 0.33. STERIS plc has a fifty-two week low of $195.47 and a fifty-two week high of $248.24. The company has a market cap of $21.42 billion, a price-to-earnings ratio of 50.20 and a beta of 0.85. The firm's fifty day moving average is $230.37 and its 200 day moving average is $228.59.

STERIS (NYSE:STE - Get Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The medical equipment provider reported $2.14 earnings per share for the quarter, topping the consensus estimate of $2.12 by $0.02. The business had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.33 billion. STERIS had a net margin of 8.02% and a return on equity of 13.78%. STERIS's revenue was up 7.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.03 earnings per share. On average, equities analysts anticipate that STERIS plc will post 9.15 earnings per share for the current fiscal year.

STERIS Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 19th. Shareholders of record on Tuesday, November 19th will be paid a dividend of $0.57 per share. This represents a $2.28 annualized dividend and a yield of 1.05%. The ex-dividend date of this dividend is Tuesday, November 19th. STERIS's payout ratio is presently 52.05%.

Insider Buying and Selling at STERIS

In other news, CFO Michael J. Tokich sold 23,332 shares of the stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $247.00, for a total value of $5,763,004.00. Following the completion of the transaction, the chief financial officer now owns 42,930 shares of the company's stock, valued at approximately $10,603,710. This represents a 35.21 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 1.14% of the company's stock.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.